Interactive panel - Building a Belgian Vaccine Trial Network

Belgium has a unique opportunity to strengthen its position as a leader in vaccine R&D. But to seize it, we need to act now. This interactive panel brings together stakeholders involved in deploying and consolidating a Belgian vaccine trial network. We will start with BioWin presenting the context and key findings of its recent feasibility study, which highlighted the clear need for such a network to keep Belgium competitive globally.

Deploying the network and harmonizing practices across the ecosystem will be a real challenge. Our panel will discuss these hurdles, share strategic insights, and generate ideas for collective action.

This panel has three objectives:

• Inform the community about the main insights from the feasibility study.

• Engage national stakeholders in constructive dialogue.

• Inspire new collaborative innovation projects to support the rollout of a Belgian vaccine trial network.

This is a must-attend conversation to shape the future of vaccine trials in Belgium and ensure the country remains a leader in innovation.

Speakers: Cristelle Noirhomme (GSK), Laurence Vigneron (FAMHP), Thibault Helleputte (DNAlytics), Benjamin Booinem (Inokura), Representative from Plotkin Institute